Researchers are reworking peptide drugs so they hold up in the gut and home in on specific cells, a path toward precision medicines taken by mouth.
Recap by typeshit. Full story at The Kansas City Star on MSN.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
Researchers report that asprosin, a hunger hormone released by fat tissue, stays elevated after weight loss, which could help explain why lost pounds come back.
CME India covers an October 14 study reporting retatrutide side effects outside the gut, including a signal that the drug may paradoxically raise appetite.
Former NIGMS director Jeremy Berg walks through four decades of research behind GLP-1 drugs, from a hormone that breaks down in two minutes to weekly shots.
Loading…